Eugenics – the science of improving the human population via selective breeding or reproduction – is not a concept confined to past centuries and decades, nor to locales outside the United States.
She recalled, “The box contained hundreds of individual files, each detailing a woman’s difficulties with the side effects of Depo-Provera or detailing how she had not been informed of those side effects or detailing how she had been given the injection without her consent or by means of manipulation. This coercion, lack of informed consent and testing of the drug has obviously been gathered together in preparation for a class-action suit by the National Women’s Health Network that had never gone forward.”
But the collection did provide Kline with a rich source of material of examining the history of this contraceptive and the U.S. Food and Drug Administration’s public board of inquiry on Depo-Provera held in 1983.
“The use of Depo-Provera captures all of the controversy of this century regarding controlling fertility and who’s ultimately making the decision about who gets to reproduce. My research looks at coercion, risks not fully understood and how arguments were made for and against Depo-Provera at the time,” she explained.
For instance, it was in the Depo-Provera hearings in Washington that the manufacturer and those in favor of the drug had to first contend with the greater organizational powers and force of the feminist movement – but where that feminist movement had to argue its case by focusing narrowly on the flaws in the scientific research methodology applied when testing Depo-Provera.
In other words, those combating the use of Depo-Provera could not make a case against the drug based on morality or sentiment even though it could easily have been argued that this was a case of eugenics since the testing of the drug in the 1970s at Atlanta’s Grady Memorial Hospital Family Planning Clinic involved mostly black women in public assistance.
Instead, because of FDA strictures related to evidence supplied at its board of inquiry hearings, opponents of the drug had to channel their arguments on the science then available on Depo-Provera.
“Of course,” said Kline, “It was and is very difficult to separate science from the society that produced it. There was a reason, given the understood risks of Depo-Provera, that its testing was done on poor women in the U.S. and on women in developing countries.”
Still, at the Depo-Provera hearings of 1983, those against the use of Depo-Provera were able to introduce the concept that the FDA’s established cost/benefit analysis of a drug should include quality of life issues and that dismissing female patient’s complaints about crippling side effects was not just “sexist,” it was bad science.
Another outcome of the FDA 1983 inquiry into Depo-Provera and the publicity surrounding the hearings was the first national conference on black women’s health held in Atlanta in 1983.
The larger message, according to Kline, is that eugenics is more than simply an embarrassing mistake of the past. The popular belief that technology and regulation of sexual fertility would lead to healthier, stronger, more self-reliant population carried over in the 1970s, ‘80s and even today.
Kline's research was funded by a Harvard University Countway Library of Medicine, a Summer Research Fellowship from the Charles Phelps Taft Research Center at UC and a UC Research Council Grant.
M.B. Reilly | EurekAlert!
Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School
Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
19.11.2018 | Science Education
19.11.2018 | Ecology, The Environment and Conservation
19.11.2018 | Life Sciences